Description

Methyl 4-(2-([Amino(Imino)Methyl]Amino)-4-Methyl-1,3-Thiazol-5-Yl)Benzoate CAS NO 232595-03-8 is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant commercial value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular design. It is primarily sought after by research institutions, custom synthesis organizations, and pharmaceutical manufacturers engaged in the development of new chemical entities and specialty fine chemicals.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, especially those targeting specific enzymatic pathways.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization processes in academic and industrial labs.
• Custom Synthesis: Employed by contract research and manufacturing organizations (CRMOs) for the production of bespoke molecules and reference standards.
• API Manufacturing: Integral in the production chain for active pharmaceutical ingredients requiring a functionalized thiazole-benzoate core structure.
• Biochemical Research: Potential use as a tool compound or inhibitor in biochemical assays due to its specific molecular recognition properties.

Basic Information

Product Name	Methyl 4-(2-([Amino(Imino)Methyl]Amino)-4-Methyl-1,3-Thiazol-5-Yl)Benzoate
CAS No.	232595-03-8
Molecular Formula	C14H16N4O2S
Molecular Weight	304.37 g/mol
Synonyms	Methyl 4-(2-[(aminoiminomethyl)amino]-4-methyl-1,3-thiazol-5-yl)benzoate; 5-(4-Methoxycarbonylphenyl)-4-methyl-1,3-thiazol-2-ylguanidine; 2-Guanidino-4-methyl-5-(4-methoxycarbonylphenyl)thiazole; Methyl 4-(2-guanidino-4-methyl-1,3-thiazol-5-yl)benzoate; 232595-03-8; AGN-PC-0E7Q0P; BDBM50102657; HY-101966; ZINC000003869756; Thiazole-guanidine benzoate derivative
EINECS	Contact for details

Quality Control

Our Methyl 4-(2-([Amino(Imino)Methyl]Amino)-4-Methyl-1,3-Thiazol-5-Yl)Benzoate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D and synthesis. Certificates of Analysis (COA) detailing batch-specific results are available upon request, providing full traceability and compliance data.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.